Literature DB >> 9510143

Characterization of functional thrombin receptors in human pancreatic tumor cells (MIA PACA-2).

C Rudroff1, H Schafberg, G Nowak, R Weinel, J Scheele, R Kaufmann.   

Abstract

In this article, the "tethered ligand" thrombin receptor was identified on human pancreatic tumor cells, MIA PaCa-2, using immunofluorescence studies with a monoclonal anti-thrombin receptor antibody. Pharmacological characterization, using 3H-labeled thrombin receptor activating peptide-6 (TRAP-6) as radioligand, demonstrated a single class of high-affinity binding sites (KD = 9.1+/-1.8 x 10(-7) M) and a binding capacity of 13.9+/-0.7 fmol/mg protein. These binding sites represent functional thrombin receptors, as shown by alpha-thrombin- and TRAP-6-induced mobilization of free intracellular calcium, protein kinase C translocation from cytosol to the cell membrane, and stimulation of DNA synthesis in MIA PaCa-2 cells. These results provide the first identification of tethered ligand thrombin receptor in human pancreatic cancer cells and suggest thrombin receptor involvement in mechanisms of human pancreatic tumor progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510143     DOI: 10.1097/00006676-199803000-00013

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  12 in total

1.  Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation.

Authors:  Stephan L Haas; Ralf Jesnowski; Michael Steiner; Frank Hummel; Jörg Ringel; Christine Burstein; Horst Nizze; Stefan Liebe; J Matthias Löhr
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

2.  Selected hemostatic parameters in patients with pancreatic tumors.

Authors:  Anna Deskur; Daria Sałata; Marta Budkowska; Barbara Dołęgowska; Teresa Starzyńska; Wojciech Błogowski
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

3.  PAR 1-type thrombin receptors are involved in thrombin-induced calcium signaling in human meningioma cells.

Authors:  R Kaufmann; S Patt; R Kraft; M Zieger; P Henklein; G Neupert; G Nowak
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

4.  Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues.

Authors:  M R D'Andrea; C K Derian; R J Santulli; P Andrade-Gordon
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 5.  GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets.

Authors:  Krishna Sriram; Cristina Salmerón; Shu Z Wiley; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

6.  Expression of functional protease-activated receptor 1 in human prostate cancer cell lines.

Authors:  Jian Liu; Manuela Bastian; Peter Kohlschein; Peter Schuff-Werner; Michael Steiner
Journal:  Urol Res       Date:  2003-03-25

7.  Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

Authors:  Gabriel J Villares; Maya Zigler; Hua Wang; Vladislava O Melnikova; Hong Wu; Ran Friedman; Michael C Leslie; Pablo E Vivas-Mejia; Gabriel Lopez-Berestein; Anil K Sood; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

8.  Proteinase-activated receptor-2-mediated signaling and inhibition of DNA synthesis in human pancreatic cancer cells.

Authors:  R Kaufmann; H Schafberg; G Nowak
Journal:  Int J Pancreatol       Date:  1998-10

9.  Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients.

Authors:  Faruk Tas; Senem Karabulut; Didem Tastekin; Derya Duranyildiz
Journal:  Biomed Rep       Date:  2016-02-19

10.  Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Authors:  Vladislava O Melnikova; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.